PNEUMOVAX 23

Vaccine Responses in Patients With B Cell Malignancies

Persistent Readiness Through Early Prediction Immunization Study

Vaccinating Children After Chemotherapy

Immune Response to PNEUMOVAX 23 in Healthy Adults Receiving Efgartigimod IV

Evaluation of the Safety and Immunogenicity of Sequential Administration of Prevnar 13™ and Pneumovax™ 23 in Healthy Participants 50 Years of Age and Older (V110-029)

Effect of Obesity on Immune Response to Pneumovax 23

Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly Population

Safety and Immunogenicity of a 10 Valent Pneumococcal Conjugate Vaccine (SIILPCV10) in Healthy Adults, Toddlers, Infants

The Safety, Tolerability, and Immunogenicity Profiles of a Single Dose of V114, PNEUMOVAX® 23, or PREVNAR 13® in Adults 50 Years of Age or Older (V114-002)

Revaccination With PNEUMOVAX™ 23 in Older Japanese Adults (V110-902)

A Phase III Clinical Trial to Study the Safety and Immunogenicity of Pneumovax™ 23 (V110) in Participants From the Russian Population (V110-018)

Evaluation of the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine Influsplit™ Tetra (Fluarix™ Tetra) (GSK2321138A) When Co-administered With Pneumovax™ 23 in Adults 50 Years of Age and Older

A Protocol to Collect Human Serum Samples From Healthy Adults for Use as Quality Controls Samples in GlaxoSmithKline (GSK) Biologicals' Assays

Pneumococcal Adult-dose Ranging Immunization Study

Pneumococcal Reference Standard

The Effect of Short-term Atorvastatin Treatment on Immune Responses to Pneumovax 23

Study to Evaluate the Response Rate to the Licensed Pneumovax 23™ in Elderly Population.

Pneumococcal Vaccination of Fiji Infants